Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-modulated Radiotherapy”

491 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 491 results

Not applicableStudy completedNCT02308488
What this trial is testing

Study of Prone Accelerated Breast And Nodal IMRT

Who this might be right for
Lymphedema
NYU Langone Health 97
Testing effectiveness (Phase 2)Study completedNCT00576979
What this trial is testing

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT02280356
What this trial is testing

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Not applicableStudy completedNCT04610229
What this trial is testing

Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioblastoma, Adult
Azienda USL Reggio Emilia - IRCCS 12
Not applicableStudy completedNCT01127373
What this trial is testing

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 116
Testing effectiveness (Phase 2)UnknownNCT01552239
What this trial is testing

Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance and Small Safety-margins

Who this might be right for
Soft Tissue Sarcoma of the LimbAJCC Stage II and III
Technical University of Munich 50
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06688175
What this trial is testing

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal NeoplasmsElderlyChemotherapy
The First Affiliated Hospital of Xiamen University 32
Not applicableNot Yet RecruitingNCT05909137
What this trial is testing

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
ImmunotherapyIntensity Modulated Radiation TherapyRadiotherapy+1 more
Xinqiao Hospital of Chongqing 60
Not applicableWithdrawnNCT02289807
What this trial is testing

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University
Not applicableStudy completedNCT03471741
What this trial is testing

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Who this might be right for
Breast CancerRadiation Toxicity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 451
Not applicableStudy completedNCT04276194
What this trial is testing

Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System

Who this might be right for
Malignant Central Nervous System Neoplasm
Emory University 10
Testing effectiveness (Phase 2)Study completedNCT02864849
What this trial is testing

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 81
Not applicableStudy completedNCT02949596
What this trial is testing

Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy

Who this might be right for
Anal CancerQuality of Life
Instituto do Cancer do Estado de São Paulo 19
Testing effectiveness (Phase 2)Looking for participantsNCT06939582
What this trial is testing

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

Who this might be right for
Radiation-induced Oral Mucositis
Xingchen Peng 158
Not applicableLooking for participantsNCT06364579
What this trial is testing

Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).

Who this might be right for
Anal Cancer Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Large-scale testing (Phase 3)UnknownNCT01745107
What this trial is testing

Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;

Who this might be right for
Esophageal NeoplasmEsophageal Cancer TNM Staging Primary Tumor (T) T2Esophageal Cancer TNM Staging Primary Tumor (T) T3+2 more
Chinese Academy of Medical Sciences 240
Testing effectiveness (Phase 2)Study completedNCT01166204
What this trial is testing

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

Who this might be right for
Stage I-III Non-small Cell Lung Cancer
Maastricht Radiation Oncology 300
Testing effectiveness (Phase 2)WithdrawnNCT03699033
What this trial is testing

Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Stephanie Smiddy
Large-scale testing (Phase 3)Looking for participantsNCT04448522
What this trial is testing

Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapyChemotherapy
Sun Yat-sen University 508
Next Page